Labiotech.eu

News and Trends 3 May 2017

French Biotech gets a Second Opportunity to Fight Liver Fibrosis

Genkyotex, a French biotech with an eye on NASH, has received FDA approval to initiate a Phase II trial in primary biliary cholangitis. Genkyotex’s lead candidate, GKT831, failed to prove its efficacy in a Phase II trial for diabetic nephropathy a couple of years ago. Now, the company is taking a second shot by targeting liver […]

May 3, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 May 2017

Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?

As immunotherapies are moving from large academic centers to clinics across the world, doctors are realizing that releasing the breaks of the immune system comes with serious risks – and that research on its adverse effects is lagging behind. This week, AstraZeneca’s anti-PD-L1 antibody durvalumab received FDA approval to treat patients with metastatic urothelial carcinoma, making […]

May 3, 2017 - 4 minutesmins - By Melanie De Almeida

Interview 2 May 2017

Video Interview: Meet the Inventor of the Surgical Super-glue

At our second meetup in Basel last week, Philip had the chance to talk to Maria Pereira, one of Forbes’ 30 under 30 and the scientific inventor of the technology behind Gecko Biomedical. Apart from telling us about Gecko’s progress and future plans, Maria talked about her time in Boston and why she ended up […]

May 2, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 2 May 2017

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

Belgian Celyad is giving Novartis access to its IP for the production of allogeneic CAR-T cells in a non-exclusive license agreement, worth up to €88M. Celyad is developing “off-the-shelf” therapies, based on engineering donor-derived allogeneic T cells. Despite a recent public dispute with its key rival Cellectis regarding the validity of Celyad’s US patents, Novartis has now entered a non-exclusive […]

May 2, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 2 May 2017

French HIV Cure Reduces Viral Reservoirs for the First Time Ever

Abivax has announced results from a Phase IIa trial that reveal the first proof in human of viral load reduction of hidden HIV reservoirs. Abivax is developing a functional HIV cure that, unlike current antiretroviral therapy (ART), could completely eliminate the virus and prevent it from coming back when the treatment is stopped. Results from a Phase IIa […]

May 2, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 May 2017

Entrepreneurs, Academics & Entrepreneurial Academics succeed in Berlin

With Berlin’s plethora of life science research and academia, opportunities abound for biotech entrepreneurs. Here’s how the city bridges the gap between science and business! So much research, so many opportunities for academics and entrepreneurs. Berlin boasts 35 large research institutions focused on life sciences, and around 130 hospitals — including Europe’s largest and most […]

May 2, 2017 - 5 minutesmins - By External Contributor

Interview 1 May 2017

This Founder is using Synbio to Revolutionize Genetic Medicine

Oxford Genetics founder and CEO Ryan Cawood told me about his company’s improvements to DNA design for better biologicals. Last month at Synbiobeta, I caught up with Ryan Cawood, who created one of the most successful synthetic biology companies around, Oxford Genetics. “Our direction actually took off from this conference,” he told me. “We saw […]

May 1, 2017 - 5 minutesmins - By Evelyn Warner

News and Trends 29 Apr 2017

These Bioartists Turn Cell-to-Cell Communication in your Body into Sound

Thought Collider and David Young have developed an installation that transforms the faint communication signals between your skin cells into sounds. Artist duo Thought Collider is comprised of Mike Thompson, from the UK, and Susana Cámara Leret, from Spain. Based in Amsterdam and London, they experiment with the living nature of our bodies and microorganisms. Their […]

April 29, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Apr 2017

The Tires of the Future will be made with… Dandelions?

Continental, famous producer of tires, is creating a research facility in Germany to investigate the use of rubber extracted from dandelions. An eventual switch to the material would mean less environmental impact, and maybe even better tires. The “green pet project” of Continental, a giant automotive manufacturer with almost €40Bn yearly revenues, consists of replacing conventional natural […]

April 28, 2017 - 3 minutesmins - By Denise Neves Gameiro

Startup Scout 28 Apr 2017

This Dutch Biotech Could Boost Gene Editing of Primary Cells

Located in the charming town of Utrecht in the Netherlands, Ntrans Technologies was newly founded in 2015 based on a cutting-edge intracellular delivery technology developed at the Hubrecht Institute of the Royal Netherlands Academy of Sciences. Mission: NTrans is developing the iTOP technology for its use in research and as a therapeutical platform for the delivery of bioactive molecules into […]

April 28, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 27 Apr 2017

Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation

Heptares Therapeutics has published the detailed structure and mechanism of action of a difficult-to-target GPCR protein with great therapeutic prospects. Heptares Therapeutics has published today in Nature new insights into the mechanism of action of antagonists of the protease-activated receptor 2 (PAR2), a molecule involved in metabolism and inflammatory responses. The study is part of […]

April 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Inside Labiotech 27 Apr 2017

Wait but why is Labiotech.eu based in Berlin?

After “How do you make money,” that’s the question I am asked most. Here’s the answer for all the curious people out there! As you might already know, Labiotech.eu started in France. I was studying bioengineering with Joachim (the first guy I talked to on the first day of the first year!) at Sup’Biotech, and […]

April 27, 2017 - 4 minutesmins - By Philip Hemme

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

French Biotech gets a Second Opportunity to Fight Liver Fibrosis

Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?

Video Interview: Meet the Inventor of the Surgical Super-glue

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

French HIV Cure Reduces Viral Reservoirs for the First Time Ever

Entrepreneurs, Academics & Entrepreneurial Academics succeed in Berlin

This Founder is using Synbio to Revolutionize Genetic Medicine

These Bioartists Turn Cell-to-Cell Communication in your Body into Sound

The Tires of the Future will be made with… Dandelions?

This Dutch Biotech Could Boost Gene Editing of Primary Cells

Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation

Wait but why is Labiotech.eu based in Berlin?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!